Aridis Pharmaceuticals News - ARDS

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Aridis Pharmaceuticals Inc ARDS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0936 1.63% 5.8325 5.61 6.20 5.61 5.7389 19:58:29
more quote information »

Recent News

Date Time Source Heading
1/28/202014:56PRNUSAridis Pharmaceuticals Presents APEX™ Antibody Discovery and..
1/02/202005:30PRNUSAridis Pharmaceuticals Appoints Michael A. Nazak as Chief..
11/13/201916:05PRNUSAridis Pharmaceuticals Announces Third Quarter 2019 Results
10/11/201916:16EDGARCurrent Report Filing (8-k)
10/11/201905:30PRNUSAridis Pharmaceuticals Appoints Infectious Disease Expert..
10/03/201906:03EDGARCurrent Report Filing (8-k)
9/30/201905:30PRNUSAridis Pharmaceuticals Executes License Agreement with The..
9/27/201910:41EDGARCurrent Report Filing (8-k)
9/27/201905:45PRNUSAridis Pharmaceuticals to Present AR-105 and AR-501 (Gallium..
9/27/201905:30PRNUSAridis Pharmaceuticals to Present at the 2019 Cantor Global..
9/09/201915:43EDGARCurrent Report Filing (8-k)
9/08/201916:28PRNUSAridis Pharmaceuticals to Present at the H.C. Wainwright..
9/06/201906:01EDGARNotice of Effectiveness (effect)
9/03/201916:11EDGARSecurities Registration: Employee Benefit Plan (s-8)
9/03/201916:05EDGARSecurities Registration Statement (simplified Form) (s-3)
9/03/201909:54EDGARCurrent Report Filing (8-k)
9/03/201905:30PRNUSAridis Pharmaceuticals Reports Phase 2 Clinical Trial..
8/29/201914:11EDGARAmended Statement of Beneficial Ownership (3/a)
8/29/201911:40EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
8/29/201911:39EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
8/29/201911:39EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
8/29/201911:38EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
8/29/201911:37EDGARAmended Statement of Beneficial Ownership (3/a)
8/29/201911:36EDGARAmended Statement of Beneficial Ownership (3/a)
8/29/201911:35EDGARAmended Statement of Beneficial Ownership (3/a)
8/29/201911:34EDGARAmended Statement of Beneficial Ownership (3/a)
8/29/201911:33EDGARAmended Statement of Beneficial Ownership (3/a)
8/14/201919:30EDGARStatement of Changes in Beneficial Ownership (4)
8/14/201919:29EDGARStatement of Changes in Beneficial Ownership (4)
8/14/201919:27EDGARStatement of Changes in Beneficial Ownership (4)
8/14/201916:09EDGARCurrent Report Filing (8-k)
8/12/201916:22EDGARQuarterly Report (10-q)
8/12/201916:12EDGARCurrent Report Filing (8-k)
8/12/201916:07EDGARAmended Current Report Filing (8-k/a)
8/12/201916:05PRNUSAridis Pharmaceuticals Announces Second Quarter 2019 Results
7/30/201916:06EDGARCurrent Report Filing (8-k)
7/30/201905:30PRNUSAridis Pharmaceuticals Enters Into Equity Purchase and..
7/19/201905:30PRNUSAridis Pharmaceuticals Receives Orphan Drug Designation From..
7/15/201908:06EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201917:32EDGARProxy Statement (definitive) (def 14a)
6/27/201916:01EDGARCurrent Report Filing (8-k)
6/27/201905:30PRNUSAridis Pharmaceuticals Receives Orphan Drug Designation for..
6/17/201916:07EDGARInitial Statement of Beneficial Ownership (3)
6/12/201911:53EDGARAmended Annual Report (10-k/a)
6/10/201908:41EDGARCurrent Report Filing (8-k)
6/10/201905:30PRNUSAridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister..
5/14/201916:55EDGARCurrent Report Filing (8-k)
5/14/201916:35PRNUSAridis Pharmaceuticals Announces First Quarter 2019 Results
5/14/201916:11EDGARQuarterly Report (10-q)
4/19/201906:01EDGARAmended Annual Report (10-k/a)
See more news about this stock »


Your Recent History
NASDAQ
ARDS
Aridis Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.